Latest News about DNLI
Recent news which mentions DNLI
From Benzinga
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
January 13, 2022
Tickers
DNLI
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 13, 2022
From Benzinga
Jim Cramer Says This Stock Is 'Really Cheap'
December 16, 2021
From Benzinga
From Benzinga
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
October 07, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2021
September 21, 2021
From Benzinga
President And CEO Of Denali Therapeutics Sold $1.00 Million In Stock
September 03, 2021
Tickers
DNLI
From Benzinga
My 2019 Report Card: Up 319%
August 15, 2021
From Motley Fool
74 Biggest Movers From Yesterday
July 27, 2021
From Benzinga
48 Stocks Moving In Monday's Mid-Day Session
July 26, 2021
From Benzinga
From Benzinga
Denali's Brain-Penetrant Enzyme Therapy Shows Durable Effect With CNS Impact In Hunter Syndrome
July 26, 2021
Tickers
DNLI
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.